DATE25 Jun

NIFTY 24,056 ▲ 0.14%SENSEX 77,100 ▲ 0.14%BANK NIFTY 58,177 ▲ 0.05%NIFTY IT 27,331 ▼ 0.86%NIFTY PHARMA 24,970 ▼ 0.20%MARUTI 13,745 ▲ 3.75%INFY 1,041 ▼ 1.46%BHARTIARTL 1,851 ▼ 1.42%BAJFINANCE 980 ▼ 1.06%SBIN 1,045 ▲ 1.04%ADANIENT 3,038 ▼ 1.03%ICICIBANK 1,388 ▲ 1.01%LT 4,216 ▲ 0.83%HINDUNILVR 2,174 ▲ 0.76%TITAN 4,291 ▼ 0.75%NIFTY 24,056 ▲ 0.14%SENSEX 77,100 ▲ 0.14%BANK NIFTY 58,177 ▲ 0.05%NIFTY IT 27,331 ▼ 0.86%NIFTY PHARMA 24,970 ▼ 0.20%MARUTI 13,745 ▲ 3.75%INFY 1,041 ▼ 1.46%BHARTIARTL 1,851 ▼ 1.42%BAJFINANCE 980 ▼ 1.06%SBIN 1,045 ▲ 1.04%ADANIENT 3,038 ▼ 1.03%ICICIBANK 1,388 ▲ 1.01%LT 4,216 ▲ 0.83%HINDUNILVR 2,174 ▲ 0.76%TITAN 4,291 ▼ 0.75%

Morning brief · Sunday, 28 June 2026

HDFC Life pays ₹101 crore for Emcure Pharmaceuticals stake

Market pulse

Indian markets ended the week on a quiet note, with the Nifty and Sensex inching up to close at 24,056 and 77,100 respectively, buoyed by gains in Maruti and major banks like State Bank of India and ICICI Bank. The broader gains were capped, however, by a drag from the technology and telecom sectors, as Infosys and Bharti Airtel both saw declines of over one percent.

From the investor's mind

One post worth your time, explained

@pranjalkamra · on X

India's mutual fund industry currently manages ₹81.5 lakh crore, with monthly Systematic Investment Plan (SIP) contributions exceeding ₹30,000 crore. Pranjal Kamra highlights a significant growth runway, noting that India's mutual fund Assets Under Management (AUM) represent only 19.9% of its GDP, far below the global average of 64% and the US figure of 124%. This comparison underscores the substantial potential for expansion within the Indian mutual fund sector.

Word in the street

What the wider market is buzzing about

Quality Power Electrical Equipments Limited

₹1,255Past year ▲ 86%M.cap ₹9,755 Cr

The buzz around Quality Power Electrical Equipments, a company riding the wave of India's power transmission overhaul, has captured the market's imagination. Its stock has surged nearly 86 percent over the last year, pushing its market capitalization towards ₹9,755 crore. Investors are drawn to what they see as a structural growth story. The debate, however, is heating up. While bulls point to the company's prospects, bears highlight a demanding valuation with a price-to-earnings ratio of 80. Some question whether the company’s existing product line can maintain a long-term edge. The core question is whether this is a strong business at an excessive price.

Know more about the stock

Yesterday's big moves

Lodha Developers LimitedNew PositionBlock Deal

₹947Past year ▼ 34%M.cap ₹94,686 Cr

Global asset manager Fidelity, known for its diversified, long-only approach to identifying quality growth, has acquired 1.32 crore shares of Lodha Developers (Macrotech Developers) for ₹1244.02 crore in a block deal on June 25, 2026. The shares were bought at ₹937.85 each. This move by Fidelity, a multi-cap investor managing over $5.5 trillion globally, underscores continued institutional confidence in India's leading real estate player amidst a robust residential and commercial property market. Lodha, with its strong presence in key metros and a market cap of ₹94,686 crore, has shown impressive 5-year profit CAGR of 59.0%.

Global Health LimitedNew PositionBlock Deal

₹1,312Past year ▲ 16%M.cap ₹35,258 Cr

HDFC Mutual Fund

HDFC Mutual Fund, one of India's largest and most trusted asset managers, has acquired 1 million shares of Global Health Limited (Medanta) in a block deal worth ₹130 crore. The purchase, executed at ₹1,300 per share, signals a bullish outlook on the hospital chain. Known for its quality and compounding philosophy under MD & CEO Navneet Munot, HDFC MF's investment aligns with its focus on fundamentally strong businesses. Global Health, with its multi-specialty tertiary care hospitals across North and East India and strong financials, appears to fit this investment style.

Emcure Pharmaceuticals LimitedNew PositionBlock Deal

₹1,880Past year ▲ 43%M.cap ₹35,692 Cr

HDFC Life Insurance

HDFC Life Insurance has acquired 556,954 shares of Emcure Pharmaceuticals in a ₹101.20 crore block deal at ₹1817.00 per share. This move signals institutional confidence in Emcure, a global pharmaceutical manufacturer with a diversified portfolio and strong growth financials, including a 5-year sales CAGR of 13.0% and profit CAGR of 18.0%. HDFC Life, known for its diversified investment strategies, continues to back the pharma sector. Emcure's stock has seen significant activity recently, hitting a record high today after another block deal earlier this month and an upgraded target price from a foreign brokerage.

MSP Steel & Power LimitedIncreasedSAST

₹42Past year ▲ 53%M.cap ₹2,370 Cr

MSP Steel & Power promoter Saket Agrawal has increased his stake in the company, acquiring 1.30 crore shares through open market purchases. The acquisition, valued at approximately ₹54.83 crore based on the current share price, boosts the promoter's holding from 42.82% to 45.12%. This move signals strong confidence from the Agrawal family in the integrated steel and power producer, which has seen its stock deliver a 31% CAGR over the past five years.

Oil Country Tubular LimitedIncreasedSAST

₹59Past year ▼ 39%M.cap ₹310 Cr

United Steel Allied Industries Pvt Ltd

Promoter group United Steel Allied Industries Pvt Ltd has significantly increased its stake in Oil Country Tubular, converting 41.95 lakh Optionally Convertible Preference Shares (OCPS) into equity. This conversion, valued at ₹23.95 crore at the current share price of ₹57.35, raises their holding from 33.18% to 38.17%. The move signals strong promoter confidence in the specialized tubular product maker, vital for the oil and gas sector's growth.

“Be fearful when others are greedy, and greedy when others are fearful.”

Warren Buffett

See what the smart money is buying, before the news does

Follow Kacholia, Damani, Rekha Jhunjhunwala and 300+ top investors. Every new position, bulk deal and insider trade, the moment it happens.

HDFC Life pays ₹101 crore for Emcure Pharmaceuticals stake.